Strength
500 mg/1
Manufacturer
AvPAKNDC
50268004212
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
ACETAZOLAMIDEApproval Type
Generic (ANDA)
FDA Application
ANDA207401On Market Since
7/20/2022
Pharmacological Classes
Price Statistics
The NADAC for ACETAZOLAMIDE ER 500 MG CAP has been published 182 times since Jan 4, 2023, and over the history we have for it it has declined 22.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.2755 per EA |
|---|---|
| All-time high | $0.3843 (Feb 15, 2023) |
| All-time low | $0.2206 (Nov 20, 2024) |
| 52-week high | $0.3055 |
| 52-week low | $0.2653 |
| Median price | $0.3065 |
| Average price | $0.3128 |
| Largest weekly change | -23.3% (Nov 20, 2024) |
| Weeks tracked | 182 |
| Tracking since | Jan 4, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Acetazolamide Extended-Release market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of ACETAZOLAMIDE ER 500 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for ACETAZOLAMIDE ER 500 MG CAP, manufactured by AvPAK, is $0.2755 per EA (NDC 50268004212), effective Jun 24, 2026.
How has the price of ACETAZOLAMIDE ER 500 MG CAP changed over time?
Over the history we have for it, the NADAC for ACETAZOLAMIDE ER 500 MG CAP has declined 22.3%. It has been tracked across 182 weekly CMS publications since Jan 4, 2023.
What are the highest and lowest recorded NADAC prices for ACETAZOLAMIDE ER 500 MG CAP?
Since Jan 4, 2023, the NADAC for ACETAZOLAMIDE ER 500 MG CAP has ranged from a low of $0.2206 (Nov 20, 2024) to a high of $0.3843 (Feb 15, 2023), with a median of $0.3065 per EA.
Are there cheaper alternatives to ACETAZOLAMIDE ER 500 MG CAP?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of ACETAZOLAMIDE ER 500 MG CAP, so no direct lower-cost alternative is listed.
Who manufactures ACETAZOLAMIDE ER 500 MG CAP?
ACETAZOLAMIDE ER 500 MG CAP (NDC 50268004212) is labeled by AvPAK, and CMS classifies it as a generic product.
Related Drugs
Same classification